The Claim
In individuals with insulin-resistant type 2 diabetes, elevated circulating levels of TNF-α and IL-6 are associated with elevated serum cholesterol and triglyceride concentrations.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with insulin-resistant type 2 diabetes, higher levels of the inflammatory proteins TNF-α and IL-6 occur alongside higher levels of cholesterol and triglycerides in the blood.
See the scientific wording
In insulin-resistant type 2 diabetes, elevated TNF-α and IL-6 levels are associated with higher cholesterol and triglyceride levels, suggesting a link between chronic inflammation and dyslipidemia in this population.
High levels of TNF-α and IL-6 block insulin's ability to control the liver, causing the liver to make more fat and stop removing fat from the blood, which raises cholesterol and triglyceride levels.
What the research says
1 studyIn people with type 2 diabetes, this study found higher levels of inflammation markers (TNF-alpha and IL-6), which are known to go hand-in-hand with abnormal fat levels like cholesterol and triglycerides — so yes, inflammation is likely connected to bad fat metabolism in these patients.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.